container_end_page 1294
container_issue 4
container_start_page 1292
container_title Transplantation proceedings
container_volume 30
creator Claesson, K
Mayer, A.D
Squifflet, J.- P
Grabensee, B
Eigler, F.W
Behrend, M
Vanrenterghem, Y
van Hooff, J
Morales, J.M
Johnson, R.W.G
Buchholz, B
Land, W
Forsythe, J.L.R
Neumayer, H.-H
Ericzon, B.-G
Mühlbacher, F
description
doi_str_mv 10.1016/S0041-1345(98)00246-2
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_434532</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041134598002462</els_id><sourcerecordid>79952297</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-732f27b113c622dbe7921c4c6ba86d2f0ffc35f7f2a88391f1e26ebfe8206bef3</originalsourceid><addsrcrecordid>eNqFkUFv1DAQhS0EKkvhJ1TyASE4BOxxYidcUFlRQKwEgnK2HGcsuWTt1M5S9d_jdLfLCXHy2PO9Ges9Qs44e80Zl29-MFbziou6edm1rxiDWlbwgKx4q0QFEsRDsjoij8mTnK9YuUMtTshJJ4VsoF6Rq42f4pTijD7Qb2aeMYVMS_0dgxnpZTIhT6MJ89L0GOb8lp7TddxOJvkcA32P8w1ioBdfaMMkNWGg61s7xjzF5AMW-F74lDxyZsz47HCekp8XHy7Xn6rN14-f1-ebytZKzZUS4ED1nAsrAYYeVQfc1lb2ppUDOOacFY1TDkzbio47jiCxd9gCkz06cUqq_dx8g9Ou11PyW5NudTReH55-lQp1XYwRUHj1T744M_wV3Qt5zQDqRfliryzY9Q7zrLc-WxyLXxh3WauuawA6VcBmD9oUc07ojks400ua-i5NvUSlu1bfpamXBWeHBbt-i8NRdYiv9J8f-iZbM7qSlvX5iIEQLVddwd7tMSy2__aYdLYlEouDT2hnPUT_n4_8Ab10vSk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79952297</pqid></control><display><type>article</type><title>Lipoprotein Patterns in Renal Transplant Patients: A Comparison Between FK 506 and Cyclosporine A Patients</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Claesson, K ; Mayer, A.D ; Squifflet, J.- P ; Grabensee, B ; Eigler, F.W ; Behrend, M ; Vanrenterghem, Y ; van Hooff, J ; Morales, J.M ; Johnson, R.W.G ; Buchholz, B ; Land, W ; Forsythe, J.L.R ; Neumayer, H.-H ; Ericzon, B.-G ; Mühlbacher, F</creator><creatorcontrib>Claesson, K ; Mayer, A.D ; Squifflet, J.- P ; Grabensee, B ; Eigler, F.W ; Behrend, M ; Vanrenterghem, Y ; van Hooff, J ; Morales, J.M ; Johnson, R.W.G ; Buchholz, B ; Land, W ; Forsythe, J.L.R ; Neumayer, H.-H ; Ericzon, B.-G ; Mühlbacher, F</creatorcontrib><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/S0041-1345(98)00246-2</identifier><identifier>PMID: 9636524</identifier><identifier>CODEN: TRPPA8</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adrenal Cortex Hormones - therapeutic use ; Azathioprine - therapeutic use ; Biological and medical sciences ; Cholesterol - blood ; Cyclosporine - therapeutic use ; Drug Therapy, Combination ; Drug toxicity and drugs side effects treatment ; Europe ; Follow-Up Studies ; Humans ; Immunomodulators ; Immunosuppressive Agents - therapeutic use ; Kidney Transplantation - immunology ; Kidney Transplantation - physiology ; Lipoproteins - blood ; Medical sciences ; Medicin och hälsovetenskap ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Pharmacology. Drug treatments ; Tacrolimus - therapeutic use ; Time Factors</subject><ispartof>Transplantation proceedings, 1998-06, Vol.30 (4), p.1292-1294</ispartof><rights>1998 Elsevier Science Inc.</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-732f27b113c622dbe7921c4c6ba86d2f0ffc35f7f2a88391f1e26ebfe8206bef3</citedby><cites>FETCH-LOGICAL-c477t-732f27b113c622dbe7921c4c6ba86d2f0ffc35f7f2a88391f1e26ebfe8206bef3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0041-1345(98)00246-2$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,310,311,315,781,785,790,791,886,3551,23935,23936,25145,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2338179$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9636524$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:1402242$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Claesson, K</creatorcontrib><creatorcontrib>Mayer, A.D</creatorcontrib><creatorcontrib>Squifflet, J.- P</creatorcontrib><creatorcontrib>Grabensee, B</creatorcontrib><creatorcontrib>Eigler, F.W</creatorcontrib><creatorcontrib>Behrend, M</creatorcontrib><creatorcontrib>Vanrenterghem, Y</creatorcontrib><creatorcontrib>van Hooff, J</creatorcontrib><creatorcontrib>Morales, J.M</creatorcontrib><creatorcontrib>Johnson, R.W.G</creatorcontrib><creatorcontrib>Buchholz, B</creatorcontrib><creatorcontrib>Land, W</creatorcontrib><creatorcontrib>Forsythe, J.L.R</creatorcontrib><creatorcontrib>Neumayer, H.-H</creatorcontrib><creatorcontrib>Ericzon, B.-G</creatorcontrib><creatorcontrib>Mühlbacher, F</creatorcontrib><title>Lipoprotein Patterns in Renal Transplant Patients: A Comparison Between FK 506 and Cyclosporine A Patients</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Azathioprine - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Cholesterol - blood</subject><subject>Cyclosporine - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Europe</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Immunomodulators</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Kidney Transplantation - immunology</subject><subject>Kidney Transplantation - physiology</subject><subject>Lipoproteins - blood</subject><subject>Medical sciences</subject><subject>Medicin och hälsovetenskap</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Pharmacology. Drug treatments</subject><subject>Tacrolimus - therapeutic use</subject><subject>Time Factors</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUFv1DAQhS0EKkvhJ1TyASE4BOxxYidcUFlRQKwEgnK2HGcsuWTt1M5S9d_jdLfLCXHy2PO9Ges9Qs44e80Zl29-MFbziou6edm1rxiDWlbwgKx4q0QFEsRDsjoij8mTnK9YuUMtTshJJ4VsoF6Rq42f4pTijD7Qb2aeMYVMS_0dgxnpZTIhT6MJ89L0GOb8lp7TddxOJvkcA32P8w1ioBdfaMMkNWGg61s7xjzF5AMW-F74lDxyZsz47HCekp8XHy7Xn6rN14-f1-ebytZKzZUS4ED1nAsrAYYeVQfc1lb2ppUDOOacFY1TDkzbio47jiCxd9gCkz06cUqq_dx8g9Ou11PyW5NudTReH55-lQp1XYwRUHj1T744M_wV3Qt5zQDqRfliryzY9Q7zrLc-WxyLXxh3WauuawA6VcBmD9oUc07ojks400ua-i5NvUSlu1bfpamXBWeHBbt-i8NRdYiv9J8f-iZbM7qSlvX5iIEQLVddwd7tMSy2__aYdLYlEouDT2hnPUT_n4_8Ab10vSk</recordid><startdate>19980601</startdate><enddate>19980601</enddate><creator>Claesson, K</creator><creator>Mayer, A.D</creator><creator>Squifflet, J.- P</creator><creator>Grabensee, B</creator><creator>Eigler, F.W</creator><creator>Behrend, M</creator><creator>Vanrenterghem, Y</creator><creator>van Hooff, J</creator><creator>Morales, J.M</creator><creator>Johnson, R.W.G</creator><creator>Buchholz, B</creator><creator>Land, W</creator><creator>Forsythe, J.L.R</creator><creator>Neumayer, H.-H</creator><creator>Ericzon, B.-G</creator><creator>Mühlbacher, F</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>BNKNJ</scope></search><sort><creationdate>19980601</creationdate><title>Lipoprotein Patterns in Renal Transplant Patients: A Comparison Between FK 506 and Cyclosporine A Patients</title><author>Claesson, K ; Mayer, A.D ; Squifflet, J.- P ; Grabensee, B ; Eigler, F.W ; Behrend, M ; Vanrenterghem, Y ; van Hooff, J ; Morales, J.M ; Johnson, R.W.G ; Buchholz, B ; Land, W ; Forsythe, J.L.R ; Neumayer, H.-H ; Ericzon, B.-G ; Mühlbacher, F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-732f27b113c622dbe7921c4c6ba86d2f0ffc35f7f2a88391f1e26ebfe8206bef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Azathioprine - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Cholesterol - blood</topic><topic>Cyclosporine - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Europe</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Immunomodulators</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Kidney Transplantation - immunology</topic><topic>Kidney Transplantation - physiology</topic><topic>Lipoproteins - blood</topic><topic>Medical sciences</topic><topic>Medicin och hälsovetenskap</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Pharmacology. Drug treatments</topic><topic>Tacrolimus - therapeutic use</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Claesson, K</creatorcontrib><creatorcontrib>Mayer, A.D</creatorcontrib><creatorcontrib>Squifflet, J.- P</creatorcontrib><creatorcontrib>Grabensee, B</creatorcontrib><creatorcontrib>Eigler, F.W</creatorcontrib><creatorcontrib>Behrend, M</creatorcontrib><creatorcontrib>Vanrenterghem, Y</creatorcontrib><creatorcontrib>van Hooff, J</creatorcontrib><creatorcontrib>Morales, J.M</creatorcontrib><creatorcontrib>Johnson, R.W.G</creatorcontrib><creatorcontrib>Buchholz, B</creatorcontrib><creatorcontrib>Land, W</creatorcontrib><creatorcontrib>Forsythe, J.L.R</creatorcontrib><creatorcontrib>Neumayer, H.-H</creatorcontrib><creatorcontrib>Ericzon, B.-G</creatorcontrib><creatorcontrib>Mühlbacher, F</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SwePub Conference</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Claesson, K</au><au>Mayer, A.D</au><au>Squifflet, J.- P</au><au>Grabensee, B</au><au>Eigler, F.W</au><au>Behrend, M</au><au>Vanrenterghem, Y</au><au>van Hooff, J</au><au>Morales, J.M</au><au>Johnson, R.W.G</au><au>Buchholz, B</au><au>Land, W</au><au>Forsythe, J.L.R</au><au>Neumayer, H.-H</au><au>Ericzon, B.-G</au><au>Mühlbacher, F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lipoprotein Patterns in Renal Transplant Patients: A Comparison Between FK 506 and Cyclosporine A Patients</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>1998-06-01</date><risdate>1998</risdate><volume>30</volume><issue>4</issue><spage>1292</spage><epage>1294</epage><pages>1292-1294</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><coden>TRPPA8</coden><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>9636524</pmid><doi>10.1016/S0041-1345(98)00246-2</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-1345
ispartof Transplantation proceedings, 1998-06, Vol.30 (4), p.1292-1294
issn 0041-1345
1873-2623
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_434532
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adrenal Cortex Hormones - therapeutic use
Azathioprine - therapeutic use
Biological and medical sciences
Cholesterol - blood
Cyclosporine - therapeutic use
Drug Therapy, Combination
Drug toxicity and drugs side effects treatment
Europe
Follow-Up Studies
Humans
Immunomodulators
Immunosuppressive Agents - therapeutic use
Kidney Transplantation - immunology
Kidney Transplantation - physiology
Lipoproteins - blood
Medical sciences
Medicin och hälsovetenskap
Miscellaneous (drug allergy, mutagens, teratogens...)
Pharmacology. Drug treatments
Tacrolimus - therapeutic use
Time Factors
title Lipoprotein Patterns in Renal Transplant Patients: A Comparison Between FK 506 and Cyclosporine A Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T18%3A09%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lipoprotein%20Patterns%20in%20Renal%20Transplant%20Patients:%20A%20Comparison%20Between%20FK%20506%20and%20Cyclosporine%20A%20Patients&rft.jtitle=Transplantation%20proceedings&rft.au=Claesson,%20K&rft.date=1998-06-01&rft.volume=30&rft.issue=4&rft.spage=1292&rft.epage=1294&rft.pages=1292-1294&rft.issn=0041-1345&rft.eissn=1873-2623&rft.coden=TRPPA8&rft_id=info:doi/10.1016/S0041-1345(98)00246-2&rft_dat=%3Cproquest_swepu%3E79952297%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79952297&rft_id=info:pmid/9636524&rft_els_id=S0041134598002462&rfr_iscdi=true